10X Genomics Inc TXG:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/14/24 EDT
26.56quote price arrow down-0.41 (-1.52%)
Volume
1,564,692
52 week range
24.60 - 63.57
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.56
  • 52 Week High63.57
  • 52 Week High Date07/31/23
  • 52 Week Low24.60
  • 52 Week Low Date05/01/24

Key Stats

  • Market Cap3.179B
  • Shares Out119.71M
  • 10 Day Average Volume2.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-52.54

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close26.56
  • 52 Week High63.57
  • 52 Week High Date07/31/23
  • 52 Week Low24.60
  • 52 Week Low Date05/01/24
  • Market Cap3.179B
  • Shares Out119.71M
  • 10 Day Average Volume2.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-52.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.24
  • P/E (TTM)-11.86
  • Fwd P/E (NTM)-16.52
  • EBITDA (TTM)-231.715M
  • ROE (TTM)-34.75%
  • Revenue (TTM)625.448M
  • Gross Margin (TTM)64.62%
  • Net Margin (TTM)-42.26%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 10X Genomics Inc

 

Profile

MORE
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of...
John Stuelpnagel
Independent Chairman of the Board
Serge Saxonov Ph.D.
Chief Executive Officer, Co-Founder, Director
Benjamin Hindson
President, Co-Founder, Chief Scientific Officer, Director
Justin Mcanear
Chief Financial Officer
Address
6230 Stoneridge Mall Road
Pleasanton, CA
94588
United States

Top Peers

SYMBOLLASTCHG%CHG
GH
Guardant Health Inc
24.73+0.73+3.04%
RARE
Ultragenyx Pharmaceutical Inc
40.97+0.01+0.02%
FOLD
Amicus Therapeutics Inc
9.33+0.29+3.21%
ACAD
ACADIA Pharmaceuticals Inc
14.86-0.32-2.11%
MYGN
Myriad Genetics Inc
25.36+0.43+1.72%